abagovomab 0
abciximab 17
abituzumab 3
abrilumab 0
actoxumab 3
adalimumab 7
aducanumab 3
afasevikumab 0
alacizumab_pegol 0
alemtuzumab 8
alirocumab 3
amatuximab 8
andecaliximab 0
anifrolumab 3
anrukinzumab 7
aprutumab 3
aprutumab_ixadotin 3
arcitumomab 4
ascrinvacumab 0
atezolizumab 4
atinumab 9
avelumab 3
basiliximab 0
bavituximab 6
begelomab 0
benralizumab 7
bevacizumab_beta 3
bezlotoxumab 3
bimagrumab 3
bleselumab 0
blinatumomab 9
blosozumab 8
bococizumab 10
brazikumab 3
brentuximab_vedotin 3
briakinumab 4
brodalumab 0
brolucizumab 10
brontictuzumab 3
burosumab 4
cabiralizumab 3
camrelizumab 0
canakinumab 3
cantuzumab_ravtansin 13
carlumab 7
carotuximab 0
cergutuzumab_amunaleukin2 12
cergutuzumab_amunaleukin 12
certolizumab_pegol 7
cetiximab 18
citatuzumab_bogatox 10
cixutumumab 8
clivatuzumab_tetraxetan 4
codrituzumab 13
conatumumab 8
concizumab 9
crenezumab 6
crizanlizumab 6
crotedumab 9
dacetuzumab 11
daclizumab 5
dalotuzumab 6
dapirolizumab_pegol 5
daratumumab 7
dectrekumab 3
demcizumab 10
denosumab 3
depatuxizumab 3
depatuxizumab_mafodotin 3
dezamizumab 0
dinutuximab 10
diridavumab 0
domagrozumab 0
drozitumab 0
duligotuzumab 6
durvalumab 0
dusigitumab 0
efalizumab 14
efungumab 0
eldelumab 3
elezanumab 3
elgemtumab 0
elotuzumab 4
emactuzumab 4
emapalumab 10
emibetuzumab 3
enavatuzumab 7
enfortumab_vedotin 3
enoblituzumab 0
enokizumab 6
enoticumab 4
ensituximab 6
eptinezumab 0
erenumab 4
etaracizumab 10
etrolizumab 15
evinacumab 7
evolocumab 3
farletuzumab 0
fasinumab 6
fezakinumab 3
fibatuzumab 0
ficlatuzumab 6
firivumab 14
flanvotumab 0
fletikumab 4
foralumab 3
foravirumab 6
fremanezumab 10
fresolimumab 9
fulranumab 10
futuximab 3
galcanezumab 3
ganitumab 8
gantenerumab 0
gemetuzumab 9
gemtuzumab2 8
gemtuzumab 7
gevokizumab 14
girentuximab 8
glembatumumab 12
glembatumumab_vedotin 12
guselkumab 11
ibalizumab 10
ibritumomab 0
icrucumab 0
idarucizumab 9
ifabotuzumab 0
imalumab 8
imgatuzumab 5
inclacumab 4
indatuximab_ravtansin 9
indusatumab 5
inebilizumab 8
intetumumab 3
iodine_girentuximab 6
ipilimumab 0
iratumumab 0
isatuximab 3
itolizumab 0
ixekizumab 9
labetuzumab_govitecan 8
lambrolizumab 6
lampalizumab 7
lanadelumab 12
landogrozumab 0
laprituximab 3
lebrikizumab 13
lendalizumab 11
lenzilumab 5
lifastuzumab_vedotin 4
ligelizumab 5
lilotomab 12
lirilumab 7
lodelcizumab 12
lokivetmab 6
lorvotuzumab_mertansin 0
lucatumumab 3
lumretuzumab 4
lupartumab 0
lutikizumab 9
margetuximab 9
milatuzumab 6
mirvetuximab 13
mirvetuximab_soravtansin 13
modotuximab 10
mogamulizumab 12
monalizumab 10
motavizumab 11
moxetumomab_pasudotox 11
namilumab 4
naratuximab 4
naratuximab_emtansin 4
narnatumab 7
navicixizumab2 12
navicixizumab 10
navivumab 6
necitumumab 0
nemolizumab 11
nesvacumab 0
nivolumab 3
obiltoxaximab 0
obinutuzumab 13
ocaratuzumab 9
ofatumumab 7
olaratumab 4
olokizumab 13
omalizumab 13
onartuzumab 6
ontuxizumab 7
opicinumab 9
orticumab 0
otelixizumab 6
oxelumab 3
ozanezumab 3
pamrevlumab 3
panobacumab 10
parsatuzumab 9
pasotuxizumab 7
pateclizumab 5
patritumab 4
pembrolizumab 6
perakizumab 3
pidilizumab 3
pinatuzumab_vedotin 3
plozalizumab 7
pogalizumab 6
polatuzumab_vedotin 10
ponezumab 10
prezalumab 7
pritoxaximab 10
quilizumab 4
racotumomab 7
radretumab 0
ralpancizumab 12
ramucirumab 3
ranevetmab 12
ranibizumab 0
refanezumab 7
remtolumab 5
rilotumumab 6
rinucumab 0
risankizumab 3
rituximab 0
rivabazumab 8
robatumumab 10
roledumab 5
romosozumab 3
rontalizumab 6
rosmantuzumab 3
rozanolixizumab 10
sacituzumab 12
sacituzumab_govitecan 12
samalizumab 10
sapelizumab 5
sarilumab 0
secukinumab 0
seribantumab 4
setoxaximab 17
sifalimumab 0
siltuximab 7
simtuzumab 8
sirukumab 6
solanezumab 14
solitomab 4
stamulumab 0
suptavumab 8
suvizumab 4
tabalumab 0
tadocizumab 3
tamtuvetmab 4
tanezumab 13
tarextumab 3
tavolixizumab 0
telisotuzumab 9
teplizumab 6
tesidolumab 0
tezepelumab 7
tigatuzumab 9
tildrakizumab 6
timolumab 0
tisotumab 0
tosatoxumab 15
tositumomab 0
tralokinumab 15
trastuzumab 8
tregalizumab 8
trevogrumab 5
ublituximab 6
urelumab 3
ustekinumab 13
utomilumab 3
vadastuximab 0
vadastuximab_talirin 0
vandortuzumab_vedotin 0
vantictumab 9
vanucizumab2 3
vanucizumab 7
varlilumab 3
vatelizumab 7
vedolizumab 0
veltuzumab 0
vesencumab 3
vorsetuzumab 6
vorsetuzumab_mafodotin 6
vunakizumab 7
xentuzumab 0
zatuximab 10
